MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 967-971

  Wang, Tairen ^a   Li, Fei ^a   Tang, Shengjian ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

FOXL2; MicroRNA; MiR 30a; Ovarian granulosa cell tumor

Indexed keywords

BCL2 RELATED PROTEIN A1; CYCLIN D2; FOXL2; IER3; MICRORNA; MICRORNA 30A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; WESTERN BLOTTING;

EID: 84918834700     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2723     Document Type: Article

References (23)

1. Crisponi L, Uda M, Deiana M, et al: FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics 83: 757-764, 2004.
2. De Baere E, Beysen D, Oley C, et al: FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet 72: 478-487, 2003.
3. De Baere E, Dixon MJ, Small KW, et al: Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype - phenotype correlation. Hum Mol Genet 10: 1591-1600, 2001.
4. Zlotogora J, Sagi M and Cohen T: The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35: 1020-1027, 1983.
5. Benayoun BA, Batista F, Auer J, et al: Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. Hum Mol Genet 18: 632-644, 2009.
6. Pisarska MD, Kuo FT, Bentsi-Barnes IK, Khan S and Barlow GM: LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity. Am J Physiol Endocrinol Metab 299: E101-E109, 2010.
7. Pisarska MD, Barlow G and Kuo FT: Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology. Endocrinology 152: 1199-1208, 2011.
8. Benayoun BA, Anttonen M, L'Hôte D, et al: Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation. Oncogene 32: 2739-2746, 2013.
9. Maes OC, Chertkow HM, Wang E and Schipper HM: MicroRNA: Implications for Alzheimer disease and other human CNS disorders. Curr Genomics 10: 154-168, 2009.
10. Xu J, Li Y, Wang F, et al: Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32: 976-987, 2013.
11. Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20, 2013.
12. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
13. Lee H, Park CS, Deftereos G, et al: MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol 10: 174, 2012.
14. Corrêa FJ, Tavares AB, Pereira RW and Abrão MS: A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome. Fertil Steril 93: e3-e6, 2010.
15. Kim JH, Yoon S, Park M, et al: Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene 30: 1653-1663, 2011.
16. Kalfa N, Fellous M, Boizet-Bonhoure B, et al: Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol 180: 1810-1813, 2008.
17. Kalfa N, Philibert P, Patte C, et al: Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril 87: 896-901, 2007.
18. D'Sa-Eipper C and Chinnadurai G: Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene 16: 3105-3114, 1998.
19. Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF: IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281: 998-1001, 1998.
20. Bentsi-Barnes IK, Kuo FT, Barlow GM and Pisarska MD: Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2. Fertil Steril 94: 353-356, 2010.
21. Zhang N, Wang X, Huo Q, et al: MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene 33: 3119-3128, 2014.
22. Jiang BY, Zhang XC, Su J, et al: BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. Mol Cancer 12: 61, 2013.
23. Zhong M, Bian Z and Wu Z: miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem 31: 209-218, 2013.